Definition and classification of cancer cachexia: an international consensus.
暂无分享,去创建一个
Paula Ravasco | Stefan D Anker | Andrew Wilcock | Eduardo Bruera | Giovanni Mantovani | Stein Kaasa | Vickie E Baracos | Florian Strasser | Declan Walsh | E. Bruera | P. Ravasco | Mellar P. Davis | D. Walsh | S. Kaasa | L. Radbruch | S. Anker | N. Macdonald | V. Baracos | C. Loprinzi | F. Strasser | K. Fearon | M. Muscaritoli | I. Bosaeus | R. Fainsinger | A. Jatoi | G. Mantovani | F. Ottery | A. Wilcock | Ingvar Bosaeus | Maurizio Muscaritoli | Robin L Fainsinger | Lukas Radbruch | Kenneth Fearon | Aminah Jatoi | Charles Loprinzi | Neil MacDonald | Mellar Davis | Faith Ottery
[1] A. Jatoi. Weight loss in patients with advanced cancer: effects, causes, and potential management , 2008, Current opinion in supportive and palliative care.
[2] M. Bossola,et al. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? , 2008, Clinical nutrition.
[3] F. Strasser. Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue , 2008, Current opinion in clinical nutrition and metabolic care.
[4] Mellar P. Davis,et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R. Fainsinger,et al. Applying the Delphi process to palliative care tool development: lessons learned , 2008, Supportive Care in Cancer.
[6] R. Ch.,et al. NUTRITION IN GERIATRICS. , 1963 .
[7] K. Fearon. Cancer cachexia: developing multimodal therapy for a multidimensional problem. , 2008, European journal of cancer.
[8] A. Fairchild,et al. Is pain intensity a predictor of the complexity of cancer pain management? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Robert Ross,et al. Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.
[10] J. Corner,et al. The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. , 2006, Journal of pain and symptom management.
[11] I. Bosaeus. Nutritional support in multimodal therapy for cancer cachexia , 2008, Supportive Care in Cancer.
[12] F. López‐Soriano,et al. Mechanisms to explain wasting of muscle and fat in cancer cachexia , 2007, Current opinion in supportive and palliative care.
[13] Dagny Faksvåg Haugen,et al. Symptom assessment in palliative care: a need for international collaboration. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Lisa Martin,et al. Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer , 2009, Clinical Cancer Research.
[15] H. Friess,et al. Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer , 2008, Journal of Gastrointestinal Surgery.
[16] Joseph R. Bertino,et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.
[17] Arya M. Sharma,et al. A proposed clinical staging system for obesity , 2009, International Journal of Obesity.
[18] Mellar P. Davis,et al. Components of the anorexia–cachexia syndrome: gastrointestinal symptom correlates of cancer anorexia , 2009, Supportive Care in Cancer.
[19] B. Jasmin,et al. Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures , 2009, Journal of cellular and molecular medicine.
[20] J. Kitzinger,et al. Qualitative Research: Introducing focus groups , 1995 .
[21] L. Birdsell,et al. The emerging role of computerized tomography in assessing cancer cachexia , 2009, Current opinion in supportive and palliative care.
[22] R. Wolfe,et al. Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. , 2006, The Journal of clinical endocrinology and metabolism.
[23] M. Tschöp,et al. CLINICAL STUDIES , 2022 .
[24] F. López‐Soriano,et al. The role of cytokines in cancer cachexia , 1999, Medicinal research reviews.
[25] C. Tishelman,et al. The use of artificial nutrition among cancer patients enrolled in palliative home care services , 2009, Palliative medicine.
[26] P. Ponikowski,et al. Cachexia: a new definition. , 2008, Clinical nutrition.
[27] F. Strasser,et al. Fighting a losing battle: eating-related distress of men with advanced cancer and their female partners. A mixed-methods study , 2007, Palliative medicine.
[28] L. Mccargar,et al. Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment , 2009, Head & neck.
[29] F. Strasser. Appraisal of current and experimental approaches to the treatment of cachexia , 2007, Current opinion in supportive and palliative care.
[30] K. Fearon,et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.
[31] L. Mccargar,et al. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment , 2009, Clinical Cancer Research.
[32] Reader,et al. An exploration of the experience of cancer cachexia: what patients and their families want from healthcare professionals , 2010 .
[33] L. Mariani,et al. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. , 2009, JPEN. Journal of parenteral and enteral nutrition.
[34] S. Heymsfield,et al. Epidemiology of sarcopenia among the elderly in New Mexico. , 1998, American journal of epidemiology.
[35] Tony Reiman,et al. Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity , 2007, Clinical Cancer Research.
[36] Y. Kusui. Loss of Appetite , 1963, Science.
[37] K. Fox,et al. Estimation of Cachexia among Cancer Patients Based on Four Definitions , 2009, Journal of oncology.
[38] G. Biolo,et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.
[39] H. Andreyev,et al. The views and practice of oncologists towards nutritional support in patients receiving chemotherapy , 2006, British Journal of Cancer.
[40] Stephen J. Clarke,et al. Nutritional Assessment in Cancer: Comparing the Mini-Nutritional Assessment (MNA) With the Scored Patient-Generated Subjective Global Assessment (PGSGA) , 2005, Nutrition and cancer.
[41] A. Hildreth,et al. A questionnaire study of the approach to the anorexia–cachexia syndrome in patients with cancer by staff in a district general hospital , 2009, Supportive Care in Cancer.
[42] Tony Reiman,et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. , 2008, The Lancet. Oncology.
[43] Kevin D Hall,et al. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. , 2009, The American journal of clinical nutrition.
[44] A. Hildreth,et al. Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome , 2009, Palliative medicine.
[45] J. Ross,et al. Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy. , 2009, The American journal of clinical nutrition.
[46] K. Fearon,et al. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. , 2006, The American journal of clinical nutrition.
[47] H. Kauczor,et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia , 2009, Acta oncologica.
[48] G. Murray,et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.